Procter & Gamble Health informs about change in senior management personnel

07 Dec 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirement) Regulations, 2015, Procter & Gamble Health has informed that Ketan Kotadiya, shall cease to be Regulatory Affairs leader, effective December 6, 2024, due a change in his assignment at P&G. A copy of letter from Ketan Kotadiya is enclosed. Further, Nidhi Shroff will take over as Regulatory Affairs leader effective December 7, 2024. A brief profile of Shroff is enclosed.

The above information is a part of company’s filings submitted to BSE.

Procter&Gamble Healt Share Price

5708.65 -137.75 (-2.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×